Last mentioned: Mar 10, 2026
Phased Rollout
Initial access for select enterprise customers in the life sciences sector.
Integration Announcement
Clarivate officially announces the expansion of access to regulatory intelligence within Claude.
2026 Outlook
Analysts adjust projections based on Q4 performance and AI integration.
Earnings Release
Avanos, Clarivate, and Leonardo DRS report Q4 2025 results.
Global Expansion
Full availability of integrated regulatory tools across all Claude enterprise tiers.
Q4 Strategy Launch
Companies initiate final quarter strategies for the 2025 fiscal year.
Clarivate Plc has expanded its strategic partnership with Anthropic to integrate its deep regulatory intelligence directly into the Claude AI platform. This integration provides life sciences and healthcare professionals with verified, real-time regulatory data to streamline drug development and market entry processes.
Avanos Medical and Clarivate Plc reported Q4 2025 results highlighting a shift toward high-margin specialized medical devices and AI-driven life sciences analytics. Despite macroeconomic headwinds, these entities demonstrate a sector-wide pivot toward operational efficiency and data-centric healthcare solutions.
This page surfaces every story mentioning Clarivate Plc across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Clarivate Plc was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |